{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:13:50Z","timestamp":1788430430630,"version":"build-2803163510"},"reference-count":129,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021204","name":"California State Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ekir.2026.106685","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:43:16Z","timestamp":1782862996000},"page":"106685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone Mineral Density Loss After Kidney Transplantation: Metabolic Determinants, Diagnostic Approaches, and Preventive Strategies"],"prefix":"10.1016","volume":"11","author":[{"given":"Clemens","family":"Untersulzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Pirklbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106685_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1159\/000447930","article-title":"Effect of denosumab on peripheral compartmental bone density, microarchitecture and estimated bone strength in de novo kidney transplant recipients","volume":"41","author":"Bonani","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.ekir.2026.106685_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13671","article-title":"Addressing bone quality and bone density after renal transplantation: a prospective evaluation of the evolution of trabecular bone score and bone mineral density over the first 5 years following renal transplantation in Asian patients","volume":"33","author":"Chandran","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ekir.2026.106685_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12882-023-03376-y","article-title":"The effect of Zoledronic acid on hip geometry in renal transplant recipients: a double-blind placebo-controlled randomized study","volume":"24","author":"Dabbaghmanesh","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib4","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1007\/s00431-024-05777-z","article-title":"Changes in bone density and microarchitecture in adolescents undergoing a first kidney transplantation: a prospective study","volume":"183","author":"De Mul","year":"2024","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ekir.2026.106685_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","article-title":"Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation","volume":"15","author":"Seeherunvong","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib6","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","article-title":"Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients","volume":"95","author":"Evenepoel","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106685_bib7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/ijms25031859","article-title":"Post-transplant bone disease in kidney transplant recipients: diagnosis and management","volume":"25","author":"Teh","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106685_bib8","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/ajt.13692","article-title":"Effect of twice-yearly denosumab on prevention of bone mineral density loss in de novo kidney transplant recipients: a randomized controlled trial","volume":"16","author":"Bonani","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfy306","article-title":"Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol","volume":"35","author":"Evenepoel","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00223-024-01218-z","article-title":"Long-term bone mineral density changes in kidney transplant recipients treated with denosumab: a retrospective study with nonequivalent control group","volume":"115","author":"Fassio","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106685_bib11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/TP.0000000000004538","article-title":"Current status of mineral and bone disorders in transplant recipients","volume":"107","author":"Elder","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/BRS.0000000000003917","article-title":"Dual-energy x-ray absorptiometry does not represent bone structure in patients with osteoporosis: a comparison of lumbar dual-energy x-ray absorptiometry with vertebral biopsies","volume":"46","author":"Pumberger","year":"2021","journal-title":"Spine"},{"key":"10.1016\/j.ekir.2026.106685_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2016.02.016","article-title":"High-resolution peripheral quantitative computed tomography (HR-pQCT) can assess microstructural and biomechanical properties of both human distal radius and tibia: ex vivo computational and experimental validations","volume":"86","author":"Zhou","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2026.106685_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1359\/jbmr.090822","article-title":"High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone","volume":"25","author":"Liu","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106685_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3803\/EnM.2024.1939","article-title":"Bone loss after solid organ transplantation: a review of organ-specific considerations","volume":"39","author":"Kim","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.ekir.2026.106685_bib17","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1681\/ASN.2021081081","article-title":"Natural history of bone disease following kidney transplantation","volume":"33","author":"J\u00f8rgensen","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/01.TP.0000131990.13277.28","article-title":"Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation","volume":"77","author":"Brandenburg","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2215\/CJN.0000000000000368","article-title":"Associations of changes in bone turnover markers with change in bone mineral density in kidney transplant patients","volume":"19","author":"J\u00f8rgensen","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib20","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/ajt.12425","article-title":"Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation","volume":"13","author":"Perrin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib21","doi-asserted-by":"crossref","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.106685_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fmed.2018.00211","article-title":"Mineral and bone disorders after kidney transplantation","volume":"5","author":"Vangala","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106685_bib23","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.00950110","article-title":"Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss","volume":"5","author":"Kanaan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","author":"Quarles","year":"2012","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ekir.2026.106685_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.03410321","article-title":"Bone and mineral disease in kidney transplant recipients","volume":"17","author":"Khairallah","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3949\/ccjm.87a.19039","article-title":"Glucocorticoid-induced osteoporosis: insights for the clinician","volume":"87","author":"Hayat","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ekir.2026.106685_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ecl.2021.03.002","article-title":"Glucocorticoid- and transplantation-induced osteoporosis","volume":"50","author":"Zavatta","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ekir.2026.106685_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S2213-8587(25)00251-7","article-title":"Glucocorticoid-induced osteoporosis: novel concepts and clinical implications","volume":"13","author":"Hofbauer","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106685_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100474","article-title":"Kidney transplantation, immunosuppression and the risk of fracture: clinical and economic implications","volume":"4","author":"Kuppachi","year":"2022","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2026.106685_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MNH.0b013e3283546ee0","article-title":"Management of mineral and bone disorder after kidney transplantation","volume":"21","author":"Kalantar-Zadeh","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.106685_bib31","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1093\/ndt\/gfr214","article-title":"Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease","volume":"26","author":"Westenfeld","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib32","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.3172","article-title":"mTORC1 inhibits NF-\u03baB\/NFATc1 signaling and prevents osteoclast precursor differentiation, in vitro and in mice","volume":"32","author":"Zhang","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/nep.14301","article-title":"The comprehensive incidence and risk factors of fracture in kidney transplant recipients: a meta-analysis","volume":"29","author":"Jia","year":"2024","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2026.106685_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ekir.2026.106685_bib35","first-page":"213","article-title":"TNF-\u03b1 and IL-6: the link between immune and bone system","volume":"21","author":"Wang","year":"2020","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ekir.2026.106685_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/art.38218","article-title":"Combination of tumor necrosis factor \u03b1 and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo","volume":"66","author":"Yokota","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2026.106685_bib37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2026.106685_bib38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41581-023-00736-7","article-title":"Inflammation and gut dysbiosis as drivers of CKD-MBD","volume":"19","author":"Evenepoel","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12882-025-03964-0","article-title":"Immunosuppressive therapy and nutritional diseases of patients after kidney transplantation: a systematic review","volume":"26","author":"Kajdas","year":"2025","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib40","doi-asserted-by":"crossref","first-page":"afad079","DOI":"10.1093\/ageing\/afad079","article-title":"Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control study","volume":"52","author":"Hauff","year":"2023","journal-title":"Age Ageing"},{"key":"10.1016\/j.ekir.2026.106685_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2017.0449","article-title":"Association of mental disorders and related medication use with risk for major osteoporotic fractures","volume":"74","author":"Bolton","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ekir.2026.106685_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1359\/jbmr.1999.14.3.456","article-title":"Increased risk of fracture in patients receiving solid organ transplants","volume":"14","author":"Ramsey-Goldman","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfag029","article-title":"Fracture risk after kidney transplantation: unchanged and unaddressed: a registry-based cohort study across two decades","volume":"19","author":"Ystr\u00f8m","year":"2026","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106685_bib44","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1097\/TP.0000000000004099","article-title":"Improvement of mineral and bone disorders after renal transplantation","volume":"106","author":"Ferreira","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/01.TP.0000438200.84154.1a","article-title":"FRAX predicts fracture risk in kidney transplant recipients","volume":"97","author":"Naylor","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib46","first-page":"363","article-title":"Assessment of fracture risk with FRAX and FRAXplus","volume":"160","author":"Tan","year":"2024","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.ekir.2026.106685_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00198-025-07588-w","article-title":"Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study","volume":"36","author":"Zoulakis","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib48","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0140-6736(25)01385-6","article-title":"Osteoporosis","volume":"406","author":"Ye","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2026.106685_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13697137.2021.1945027","article-title":"Fracture risk assessment by the FRAX model","volume":"25","author":"McCloskey","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.ekir.2026.106685_bib50","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/jgs.15962","article-title":"Fractures and subsequent graft loss and mortality among older kidney transplant recipients","volume":"67","author":"Salter","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ekir.2026.106685_bib51","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3390\/jcm9092941","article-title":"Timing of osteoporotic vertebral fractures in lung and heart transplantation: a longitudinal study","volume":"9","author":"Caffarelli","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.106685_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251035","article-title":"Low bone density, vertebral fracture and FRAX score in kidney transplant recipients: a cross-sectional cohort study","volume":"16","author":"Velioglu","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106685_bib53","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00198-015-3424-3","article-title":"Trabecular bone score in kidney transplant recipients","volume":"27","author":"Naylor","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib54","article-title":"Trabecular bone score improves early after successful kidney transplantation irrespective of antiresorptive therapy and changes in bone mineral density","volume":"10","author":"Str\u00f8mmen","year":"2024","journal-title":"Transplant Direct"},{"key":"10.1016\/j.ekir.2026.106685_bib55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-021-06164-2","article-title":"Reference data and calculators for second-generation HR-pQCT measures of the radius and tibia at anatomically standardized regions in White adults","volume":"33","author":"Warden","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib56","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/jbmr.3901","article-title":"HR-pQCT measures of bone microarchitecture predict fracture: systematic review and meta-analysis","volume":"35","author":"Mikolajewicz","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/TP.0000000000002906","article-title":"Bone metabolism impairment in heart transplant: results from a prospective cohort study","volume":"104","author":"Seguro","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191167","article-title":"Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation","volume":"13","author":"Schreiber","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.106685_bib59","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40620-024-02055-x","article-title":"Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation","volume":"37","author":"Alfieri","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib60","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfae293","article-title":"The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement","volume":"40","author":"J\u00f8rgensen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ajt.2022.12.007","article-title":"Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial","volume":"23","author":"Courbebaisse","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib62","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/aor.15053","article-title":"Changes in bone turnover markers associated with a single dialysis session","volume":"49","author":"Mackowiak","year":"2025","journal-title":"Artif Organs"},{"key":"10.1016\/j.ekir.2026.106685_bib63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib64","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"J\u00f8rgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106685_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00223-021-00930-4","article-title":"Practical considerations for the clinical application of bone turnover markers in osteoporosis","volume":"112","author":"Vasikaran","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106685_bib66","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/ndt\/gfag033","article-title":"Bone turnover markers in the management of CKD-associated osteoporosis - a European consensus","volume":"41","author":"Haarhaus","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib67","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.transproceed.2021.08.031","article-title":"Determinants of parathyroid hormone levels during the first year after kidney transplantation","volume":"53","author":"Smyrli","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2026.106685_bib68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/SLA.0000000000005946","article-title":"Resolution of secondary hyperparathyroidism after kidney transplantation and the effect on graft survival","volume":"278","author":"Wang","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ekir.2026.106685_bib69","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.kint.2022.04.030","article-title":"Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges","volume":"102","author":"J\u00f8rgensen","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106685_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117544","article-title":"Bone histomorphometry for the diagnosis of renal osteodystrophy - a European consensus statement","volume":"199","author":"Lafage-Proust","year":"2025","journal-title":"Bone"},{"issue":"4S1 Suppl 1","key":"10.1016\/j.ekir.2026.106685_bib71","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1016\/j.ekir.2026.106685_bib72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nep.13028","article-title":"Management of mineral and bone disorders in renal transplant recipients","volume":"22","author":"Damasiewicz","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2026.106685_bib73","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.2009-0205","article-title":"Approach to the patient with transplantation-related bone loss","volume":"94","author":"Ebeling","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2026.106685_bib74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00223-021-00837-0","article-title":"Bone mineral disease after kidney transplantation","volume":"108","author":"Torregrosa","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106685_bib75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jbmr.4469","article-title":"Cholecalciferol supplementation attenuates bone loss in incident kidney transplant recipients: a prespecified secondary endpoint analysis of a randomized controlled trial","volume":"37","author":"Tsujita","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib76","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2011-1448","article-title":"Prevention of fractures after solid organ transplantation: a meta-analysis","volume":"96","author":"Stein","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2026.106685_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13940","article-title":"Promoting bone health in children and adolescents following solid organ transplantation","volume":"25","author":"Kusumi","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib78","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00198-015-3367-8","article-title":"Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options","volume":"27","author":"Early","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41574-021-00593-z","article-title":"The health effects of vitamin D supplementation: evidence from human studies","volume":"18","author":"Bouillon","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ekir.2026.106685_bib80","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ndt\/gfad185","article-title":"Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement","volume":"39","author":"Evenepoel","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib81","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-18-0056","article-title":"Therapy of endocrine disease: denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis","volume":"179","author":"Anastasilakis","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ekir.2026.106685_bib82","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41584-023-00935-3","article-title":"Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on bone","volume":"19","author":"Ferrari","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ekir.2026.106685_bib83","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106685_bib84","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106685_bib85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11657-025-01588-3","article-title":"The 2024 UK clinical guideline for the prevention and treatment of osteoporosis","volume":"20","author":"Gregson","year":"2025","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ekir.2026.106685_bib86","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1681\/ASN.2018060656","article-title":"A randomized trial of Zoledronic acid to prevent bone loss in the first year after kidney transplantation","volume":"30","author":"Marques","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib87","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/phar.2838","article-title":"Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density","volume":"43","author":"Sayed","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ekir.2026.106685_bib88","article-title":"Interventions for preventing bone disease in kidney transplant recipients","volume":"10","author":"Palmer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ekir.2026.106685_bib89","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00198-015-3465-7","article-title":"Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials","volume":"27","author":"Wang","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib90","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/ctr.12792","article-title":"Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis","volume":"30","author":"Toth-Manikowski","year":"2016","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ekir.2026.106685_bib91","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","article-title":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106685_bib92","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ecl.2024.08.002","article-title":"Prevention and management of denosumab discontinuation rebound fractures","volume":"53","author":"Jain","year":"2024","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ekir.2026.106685_bib94","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fendo.2018.00162","article-title":"Osteoporosis therapy with denosumab in organ transplant recipients","volume":"9","author":"Brunova","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106685_bib95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2026.106685_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-022-00771-6","article-title":"Denosumab discontinuation","volume":"21","author":"S\u00f8lling","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106685_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117325","article-title":"Multiple vertebral fractures after antiosteoporotic medications discontinuation: a comparative study to evaluate the potential rebound effect of denosumab","volume":"190","author":"Mart\u00edn-P\u00e9rez","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2026.106685_bib98","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jbmr.4335","article-title":"Fractures after denosumab discontinuation: a retrospective study of 797 cases","volume":"36","author":"Burckhardt","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib99","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.43179","article-title":"Expert perspective: how, when, and why to potentially stop antiresorptive drugs in osteoporosis","volume":"77","author":"Adami","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ekir.2026.106685_bib100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106685_bib101","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41584-025-01287-w","article-title":"Parathyroid hormone receptor agonists in the management of osteoporosis","volume":"21","author":"Fuggle","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ekir.2026.106685_bib102","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-016-3534-6","article-title":"Teriparatide for osteoporosis: importance of the full course","volume":"27","author":"Lindsay","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib103","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society\u2217 Clinical Practice Guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ekir.2026.106685_bib104","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","article-title":"Effect of teriparatide on early bone loss after kidney transplantation","volume":"8","author":"Cejka","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2026.106685_bib105","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s11255-025-04383-8","article-title":"Efficacy and safety of teriparatide in kidney transplant recipients with osteoporosis and low bone turnover: a real-world experience","volume":"57","author":"Vetrano","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib106","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/TP.0b013e3182247b98","article-title":"Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports","volume":"92","author":"Nogueira","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bcp.2019.05.024","article-title":"Abaloparatide, the second generation osteoanabolic drug: molecular mechanisms underlying its advantages over the first-in-class teriparatide","volume":"166","author":"Bhattacharyya","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ekir.2026.106685_bib108","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","article-title":"Abaloparatide exerts bone anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide","volume":"103","author":"Makino","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106685_bib109","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00198-025-07440-1","article-title":"PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis","volume":"36","author":"Beaudart","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106685_bib110","article-title":"PTH\/PTHrP analogues as osteoanabolic treatment in patients with osteoporosis","volume":"165","author":"Casado","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ekir.2026.106685_bib111","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjag013","article-title":"Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 yr of the Phase 2 paTH forward trial","author":"Rubin","year":"2026","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib112","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11914-025-00905-6","article-title":"PTH substitution therapy for chronic hypoparathyroidism: PTH 1\u201384 and palopegteriparatide","volume":"23","author":"Palermo","year":"2025","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106685_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf049","article-title":"Romosozumab for managing severe osteoporosis in patients undergoing kidney transplantation: a retrospective case series","volume":"9","author":"Tominaga","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ekir.2026.106685_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6570","article-title":"Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics","volume":"12","author":"Bovijn","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ekir.2026.106685_bib115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jbmr\/zjaf164","article-title":"Considerations regarding the use of Romosozumab in a patient at high risk for cardiovascular disease","volume":"41","author":"McClung","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106685_bib116","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jocd.2016.03.003","article-title":"Best practices for dual-energy x-ray absorptiometry measurement and reporting: international society for clinical densitometry guidance","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.ekir.2026.106685_bib117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s40520-024-02736-4","article-title":"The least significant change on bone mineral density scan increased in patients with higher degrees of obesity","volume":"36","author":"Dorilleau","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.ekir.2026.106685_bib118","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae143","article-title":"Application of artificial intelligence to chronic kidney disease mineral bone disorder","volume":"17","author":"Lederer","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106685_bib119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semnephrol.2012.12.019","article-title":"Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients","volume":"33","author":"Evenepoel","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2026.106685_bib120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.surg.2021.03.067","article-title":"Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients","volume":"171","author":"Sutton","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.ekir.2026.106685_bib121","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40265-019-01074-4","article-title":"Management of post-transplant hyperparathyroidism and bone disease","volume":"79","author":"Delos Santos","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ekir.2026.106685_bib122","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.transproceed.2012.09.070","article-title":"Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation","volume":"44","author":"S\u00e1nchez Fructuoso","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2026.106685_bib123","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/TP.0b013e31826c3968","article-title":"Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis","volume":"94","author":"Cohen","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2026.106685_bib124","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2362.2007.01874.x","article-title":"The role of calcimimetics in the treatment of hyperparathyroidism","volume":"37","author":"W\u00fcthrich","year":"2007","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ekir.2026.106685_bib125","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13988","article-title":"Long-term results of a randomized study comparing parathyroidectomy with Cinacalcet for treating tertiary hyperparathyroidism","volume":"34","author":"Moreno","year":"2020","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ekir.2026.106685_bib126","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12020-025-04189-9","article-title":"Calcimimetics or parathyroidectomy for kidney transplant recipients: is there still a question? a systematic review, meta-analysis and trial sequential analysis","volume":"88","author":"Koimtzis","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.ekir.2026.106685_bib127","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MNH.0000000000000840","article-title":"Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach","volume":"32","author":"Disthabanchong","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.106685_bib128","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/ckj\/sfac050","article-title":"A roadmap to parathyroidectomy for kidney transplant candidates","volume":"15","author":"Cianciolo","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106685_bib129","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MOP.0000000000001290","article-title":"Bone health in children undergoing solid organ transplantation","volume":"35","author":"Pinto","year":"2023","journal-title":"Curr Opin Pediatr"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:19:59Z","timestamp":1788427199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926029177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":129,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2468024926029177"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106685","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Mineral Density Loss After Kidney Transplantation: Metabolic Determinants, Diagnostic Approaches, and Preventive Strategies","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106685"}}